FDA Drug Application (103749) for ZENAPAX by HOFFMAN-LA ROCHE

Back to FDA Applications sponsored by HOFFMAN-LA ROCHE

Application Number103749
Product Number001
FormVIAL
Dosage25MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZENAPAX
Active IngredientDACLIZUMAB

Active IngredientCount
List of drugs with Active Ingredient DACLIZUMAB2


Back to FDA Applications sponsored by HOFFMAN-LA ROCHE